Analystreport

Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) was upgraded by analysts at Credit Suisse Group AG from an "underperform" rating to a "neutral" rating. They now have

Satsuma Pharmaceuticals, Inc. - Common stock  (STSA) 
Last satsuma pharmaceuticals, inc. - common stock earnings: 3/10 04:01 pm Check Earnings Report